You have read all your free articles, to continue reading subscribe to read the rest of this content.
Patrick Greatrex has been appointed the new CEO of Medtech company Vivo Line Medical, taking office March 9. He succeeds Peter Sebelius. Previously Greatrex was CEO of CMC Contrast, CEO of Combigene and vice president of Glycorex Transplantation. He also worked on business development for Gambro.Already a subscriber Login You…
Following a one-year succession process, Miguel Calado will succeed Rabbe Klemets, who is moving into an advisory position. Non-executive board member, Mads Laustsen, will assume Calado's previous role of Vice Chairman. An experienced board member Since joining Nanoform’s board last year as VAlready a subscriber Login You have read all…
Swedish Orphan Biovitrum has announced that Birgitte Volck, M.D., Ph.D., Senior Vice President of Development and Chief Medical Officer (CMO) of Sobi, will leave the company to join the rare disease research group at GlaxoSmithKline as Head of R&D Rare Diseases. Birgitte will work through a sixAlready a subscriber Login You…
Omnio has appointed Ulrika Norin, who has a long history of working with drug development startups, as its new CEO. “I am excited look forward to being a part of Omnio’s team. We have made significant progress in finding identifying ways to help difficulthard-to-treat heal patients with theirAlready a subscriber…
